Press "Enter" to skip to content

New patent for Janssen Pharms drug SPRAVATO

1
Copyright © DrugPatentWatch. Originally published at New patent for Janssen Pharms drug SPRAVATO

Annual Drug Patent Expirations for SPRAVATO
Annual Drug Patent Expirations for SPRAVATO

Spravato is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

This drug has seven patent family members in seven countries.

The generic ingredient in SPRAVATO is esketamine hydrochloride. One supplier is listed for this compound. Additional details are available on the esketamine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Janssen Pharms drug SPRAVATO
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions